Copyright Reports & Markets. All rights reserved.

Global Respiratory Syncytial Virus Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Direct Fluorescent Antibody Method
      • 1.4.3 Rapid Antigen Diagnostic Tests
      • 1.4.4 Molecular Diagnostics
      • 1.4.5 Chromatographic Immunoassay
      • 1.4.6 Diagnostic Imaging
      • 1.4.7 Gel Microdroplets
      • 1.4.8 Flow Cytometry
      • 1.4.9 Other
    • 1.5 Market by Application
      • 1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Laboratory
      • 1.5.4 Clinics
      • 1.5.5 Homecare
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Respiratory Syncytial Virus Diagnostics Market Size
    • 2.2 Respiratory Syncytial Virus Diagnostics Growth Trends by Regions
      • 2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Regions (2014-2025)
      • 2.2.2 Respiratory Syncytial Virus Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Respiratory Syncytial Virus Diagnostics Market Size by Manufacturers
      • 3.1.1 Global Respiratory Syncytial Virus Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Respiratory Syncytial Virus Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Respiratory Syncytial Virus Diagnostics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 5.2 Respiratory Syncytial Virus Diagnostics Key Players in United States
    • 5.3 United States Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 5.4 United States Respiratory Syncytial Virus Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 6.2 Respiratory Syncytial Virus Diagnostics Key Players in Europe
    • 6.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 6.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application

    7 China

    • 7.1 China Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 7.2 Respiratory Syncytial Virus Diagnostics Key Players in China
    • 7.3 China Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 7.4 China Respiratory Syncytial Virus Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 8.2 Respiratory Syncytial Virus Diagnostics Key Players in Japan
    • 8.3 Japan Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 8.4 Japan Respiratory Syncytial Virus Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 9.2 Respiratory Syncytial Virus Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 9.4 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size by Application

    10 India

    • 10.1 India Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 10.2 Respiratory Syncytial Virus Diagnostics Key Players in India
    • 10.3 India Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 10.4 India Respiratory Syncytial Virus Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Respiratory Syncytial Virus Diagnostics Market Size (2014-2019)
    • 11.2 Respiratory Syncytial Virus Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Type
    • 11.4 Central & South America Respiratory Syncytial Virus Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Becton Dickinson
      • 12.1.1 Becton Dickinson Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.1.5 Becton Dickinson Recent Development
    • 12.2 Abbott Laboratories
      • 12.2.1 Abbott Laboratories Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.2.5 Abbott Laboratories Recent Development
    • 12.3 Alere
      • 12.3.1 Alere Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.3.4 Alere Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.3.5 Alere Recent Development
    • 12.4 Beckman Coulter/Danaher
      • 12.4.1 Beckman Coulter/Danaher Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.4.5 Beckman Coulter/Danaher Recent Development
    • 12.5 Bio-Rad Laboratories
      • 12.5.1 Bio-Rad Laboratories Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.5.5 Bio-Rad Laboratories Recent Development
    • 12.6 Coris BioConcept
      • 12.6.1 Coris BioConcept Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.6.5 Coris BioConcept Recent Development
    • 12.7 DiaSorin SPA
      • 12.7.1 DiaSorin SPA Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.7.5 DiaSorin SPA Recent Development
    • 12.8 Eiken Chemical
      • 12.8.1 Eiken Chemical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.8.5 Eiken Chemical Recent Development
    • 12.9 Elitech Group
      • 12.9.1 Elitech Group Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.9.4 Elitech Group Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.9.5 Elitech Group Recent Development
    • 12.10 Fujirebio
      • 12.10.1 Fujirebio Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Respiratory Syncytial Virus Diagnostics Introduction
      • 12.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2014-2019)
      • 12.10.5 Fujirebio Recent Development
    • 12.11 Grifols
    • 12.12 Hoffmann La Roche
    • 12.13 Hologic
    • 12.14 Novartis Diagnostics
    • 12.15 Ortho Clinical Diagnostics
    • 12.16 Roche Diagnostics
    • 12.17 Scienion

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
      North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, and more and more government initiatives, China, India, Japan and Malaysia are expected to become the fastest growing markets in the region.
      In 2018, the global Respiratory Syncytial Virus Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Respiratory Syncytial Virus Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Respiratory Syncytial Virus Diagnostics development in United States, Europe and China.

      The key players covered in this study
      Becton Dickinson
      Abbott Laboratories
      Alere
      Beckman Coulter/Danaher
      Bio-Rad Laboratories
      Coris BioConcept
      DiaSorin SPA
      Eiken Chemical
      Elitech Group
      Fujirebio
      Grifols
      Hoffmann La Roche
      Hologic
      Novartis Diagnostics
      Ortho Clinical Diagnostics
      Roche Diagnostics
      Scienion

      Market segment by Type, the product can be split into
      Direct Fluorescent Antibody Method
      Rapid Antigen Diagnostic Tests
      Molecular Diagnostics
      Chromatographic Immunoassay
      Diagnostic Imaging
      Gel Microdroplets
      Flow Cytometry
      Other

      Market segment by Application, split into
      Hospitals
      Laboratory
      Clinics
      Homecare

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Respiratory Syncytial Virus Diagnostics status, future forecast, growth opportunity, key market and key players.
      To present the Respiratory Syncytial Virus Diagnostics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Respiratory Syncytial Virus Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now